Rheumatic presentations of Guillain-Barré syndrome as a diagnostic challenge: A case series.

Arthralgia Back pain Cerebrospinal fluid Guillain–Barré syndrome Myalgia Pain Paralysis

Journal

Joint bone spine
ISSN: 1778-7254
Titre abrégé: Joint Bone Spine
Pays: France
ID NLM: 100938016

Informations de publication

Date de publication:
05 2021
Historique:
received: 26 10 2020
accepted: 29 12 2020
pubmed: 31 1 2021
medline: 29 6 2021
entrez: 30 1 2021
Statut: ppublish

Résumé

Guillain-Barré syndrome (GBS) is an immune-mediated acute polyradiculoneuritis often in post-infectious context. It is a therapeutic emergency as early treatment may prevent disabilities. Pain in GBS has been described extensively, may precede neurological symptoms and bring the patient to rheumatology departments in the first place. To describe the clinical presentations and diagnosis of GBS cases referred to rheumatology departments. For this retrospective case-series, we screened patients of the rheumatology department (university hospitals of Strasbourg), whose hospitalization records were associated with the ICD-10 Code G61.0 (GBS) from 1993 to 2020. We included patients fulfilling the 1990 NINDS criteria and level one of the Brighton collaboration criteria. We measured the time from symptoms onset to admission and from admission to lumbar puncture as a marker of outpatient and inpatient diagnosis delay, respectively. We describe 8 GBS cases. Six had nociceptive-like prodromal pain: back pain (n=3), peripheral arthralgia (n=1) or diffuse myalgia (n=3). The median time from symptoms onset to admission was 7days [range: 3-60] and the median time from admission to lumbar puncture was 2days [range: 0-8]. Two patients became severely tetraparetic, one requiring intubation. At last follow-up (median: 5.5years; range: 0.5-23years), 4 patients had recovered completely and 4 kept disabilities. Rheumatic presentations of GBS are rare and diverse. Rheumatologists should be aware of this presentation because early diagnosis and treatment may prevent rapid motor worsening. Rapidly progressive symmetric weakness and areflexia appear as the best clinical diagnosis markers.

Sections du résumé

BACKGROUND
Guillain-Barré syndrome (GBS) is an immune-mediated acute polyradiculoneuritis often in post-infectious context. It is a therapeutic emergency as early treatment may prevent disabilities. Pain in GBS has been described extensively, may precede neurological symptoms and bring the patient to rheumatology departments in the first place.
OBJECTIVE
To describe the clinical presentations and diagnosis of GBS cases referred to rheumatology departments.
METHOD
For this retrospective case-series, we screened patients of the rheumatology department (university hospitals of Strasbourg), whose hospitalization records were associated with the ICD-10 Code G61.0 (GBS) from 1993 to 2020. We included patients fulfilling the 1990 NINDS criteria and level one of the Brighton collaboration criteria. We measured the time from symptoms onset to admission and from admission to lumbar puncture as a marker of outpatient and inpatient diagnosis delay, respectively.
RESULTS
We describe 8 GBS cases. Six had nociceptive-like prodromal pain: back pain (n=3), peripheral arthralgia (n=1) or diffuse myalgia (n=3). The median time from symptoms onset to admission was 7days [range: 3-60] and the median time from admission to lumbar puncture was 2days [range: 0-8]. Two patients became severely tetraparetic, one requiring intubation. At last follow-up (median: 5.5years; range: 0.5-23years), 4 patients had recovered completely and 4 kept disabilities.
CONCLUSIONS
Rheumatic presentations of GBS are rare and diverse. Rheumatologists should be aware of this presentation because early diagnosis and treatment may prevent rapid motor worsening. Rapidly progressive symmetric weakness and areflexia appear as the best clinical diagnosis markers.

Identifiants

pubmed: 33515790
pii: S1297-319X(21)00016-6
doi: 10.1016/j.jbspin.2021.105144
pii:
doi:

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

105144

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2021. Published by Elsevier Masson SAS.

Auteurs

Stanislas Demuth (S)

Service de rhumatologie, Centre National de Référence des Maladies Auto-Immunes (RESO), Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France.

Renaud Felten (R)

Service de rhumatologie, Centre National de Référence des Maladies Auto-Immunes (RESO), Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France.

Christelle Sordet (C)

Service de rhumatologie, Centre National de Référence des Maladies Auto-Immunes (RESO), Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France.

Emmanuel Chatelus (E)

Service de rhumatologie, Centre National de Référence des Maladies Auto-Immunes (RESO), Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France.

Jean-Baptiste Chanson (JB)

Service de neurologie, Hôpitaux Universitaires de Strasbourg, 1, avenue Molière, 67000 Strasbourg, France.

Laurent Arnaud (L)

Service de rhumatologie, Centre National de Référence des Maladies Auto-Immunes (RESO), Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France. Electronic address: laurent.arnaud@chru-strasbourg.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH